Teladoc, Inc. (NYSE:TDOC) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Wednesday.

Other equities research analysts have also recently issued research reports about the company. Canaccord Genuity reaffirmed a “buy” rating and set a $42.00 price target (up previously from $34.00) on shares of Teladoc in a report on Tuesday, June 20th. Chardan Capital lifted their price target on Teladoc from $30.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, June 20th. Craig Hallum cut Teladoc from a “buy” rating to a “hold” rating and lifted their price target for the company from $28.00 to $32.00 in a report on Friday, May 12th. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $40.00 price target (up previously from $27.00) on shares of Teladoc in a report on Friday, June 9th. Finally, Cowen and Company reaffirmed an “outperform” rating and set a $39.00 price target (up previously from $36.00) on shares of Teladoc in a report on Thursday, August 3rd. One analyst has rated the stock with a sell rating, three have issued a hold rating and nine have given a buy rating to the company’s stock. Teladoc has a consensus rating of “Buy” and a consensus price target of $35.55.

Teladoc (NYSE TDOC) opened at 31.75 on Wednesday. Teladoc has a 52-week low of $14.00 and a 52-week high of $36.90. The firm’s market cap is $1.80 billion. The firm’s 50-day moving average price is $31.91 and its 200 day moving average price is $28.97.

Teladoc (NYSE:TDOC) last released its quarterly earnings results on Wednesday, August 2nd. The health services provider reported ($0.28) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.26) by $0.02. The business had revenue of $44.60 million for the quarter, compared to the consensus estimate of $44.39 million. Teladoc had a negative net margin of 47.75% and a negative return on equity of 19.88%. The business’s quarterly revenue was up 68.3% on a year-over-year basis. During the same period last year, the firm posted ($0.38) EPS. On average, equities analysts anticipate that Teladoc will post ($1.44) earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Teladoc, Inc. (TDOC) Rating Increased to Hold at BidaskClub” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/09/08/teladoc-inc-tdoc-rating-increased-to-hold-at-bidaskclub.html.

In related news, insider Adam C. Vandervoort sold 53,806 shares of the business’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $30.92, for a total transaction of $1,663,681.52. Following the sale, the insider now owns 33,008 shares of the company’s stock, valued at $1,020,607.36. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 4.47% of the stock is owned by insiders.

A number of institutional investors have recently bought and sold shares of the business. FMR LLC grew its position in Teladoc by 1.3% in the second quarter. FMR LLC now owns 8,209,737 shares of the health services provider’s stock worth $284,879,000 after buying an additional 106,500 shares during the last quarter. Wellington Management Group LLP grew its position in Teladoc by 38.9% in the first quarter. Wellington Management Group LLP now owns 4,228,082 shares of the health services provider’s stock worth $105,701,000 after buying an additional 1,183,435 shares during the last quarter. BlackRock Inc. grew its position in Teladoc by 42.9% in the second quarter. BlackRock Inc. now owns 3,844,402 shares of the health services provider’s stock worth $133,400,000 after buying an additional 1,154,852 shares during the last quarter. Vanguard Group Inc. grew its position in Teladoc by 11.5% in the second quarter. Vanguard Group Inc. now owns 3,041,725 shares of the health services provider’s stock worth $105,547,000 after buying an additional 314,646 shares during the last quarter. Finally, Alliancebernstein L.P. grew its position in Teladoc by 22.2% in the second quarter. Alliancebernstein L.P. now owns 2,793,590 shares of the health services provider’s stock worth $96,938,000 after buying an additional 507,390 shares during the last quarter.

About Teladoc

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Analyst Recommendations for Teladoc (NYSE:TDOC)

Receive News & Stock Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related stocks with our FREE daily email newsletter.